Hercules Capital Inc HTGC

NYS: HTGC | ISIN: US4270965084 2/05/2024

19,30 USD (0,00%)

(0,00%) 2/05/2024

Toon enkel gratis nieuws

30 april 2024 · SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab · Persbericht

22 december 2023 · enGene Announces Expanded $50 Million Debt Facility with Hercules Capital · Persbericht

24 juli 2023 · Heron Therapeutics Announces $30 Million Private Placement Financing · Persbericht

15 mei 2023 · Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital · Persbericht

14 maart 2023 · EPAM Welcomes DeAnne Aguirre to its Board of Directors · Persbericht

14 maart 2023 · Gibraltar Business Capital Launches Gibraltar Equipment Finance · Persbericht

2 februari 2023 · Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD® · Persbericht

16 november 2022 · Oak Street Health Secures $300 Million in Financing from Hercules Capital and Silicon Valley Bank · Persbericht

1 september 2022 · Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital · Persbericht

27 september 2021 · Corium Secures $235 Million in Debt Financing · Persbericht

12 mei 2021 · Gibraltar Business Capital Announces $150MM Line of Credit with Bank of America · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe